Lacosamide Fresenius Kabi 10 mg / ml solution for infusion

Licence status
Authorised: 03/06/2022
Active substances
Lacosamide
Dosage Form
Solution for infusion
Licence number
PA2059/078/001
Licence holder
Fresenius Kabi Deutschland GmbH

Product documents

Licence information

ATC code
N03AX18 lacosamide
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
03/06/2022